POF seminar: Inventions in life sciences: What’s patentable?

Please note that this event has already occurred. Go back to events to see upcoming events.

Patents for inventions in the field of life sciences, perhaps more so than any other field of invention, can be ethically and morally contentious. This has recently played out in the debate surrounding the BRCA gene mutations, where public access to patented technology was a key issue. As a result, patent offices around the world have adopted a range of approaches and requirements for determining what can and cannot be patented.

At this seminar, Dr Leigh Guerin will look at the practice of patent offices in major jurisdictions when dealing with life science inventions. Leigh will also discuss the issues that may arise when attempting to protect inventions, including:

  • medical treatments and diagnostics
  • genetically-engineered organisms
  • genes and gene therapies
  • stem-cells
  • reproductive technologies.

About the presenter

Dr Leigh Guerin is a Patent Attorney at Phillips Ormonde Fitzpatrick and has a strong research background in immunology and reproductive and developmental biology. Leigh is experienced in a wide range of biomedical technologies, such as protein and peptide chemistry and therapeutics, diagnostics, methods of therapeutic treatment, molecular biology and genetic therapies.

  • Date: Wednesday 29 March, 2017
  • Time: 12.15pm for a 12.30pm start (Melbourne and Sydney)11.45am for a 12.00pm start (Adelaide)
  • Location:

    Melbourne office

    Phillips Ormonde Fitzpatrick
    Level 16, 333 Collins Street

    Sydney office
    Phillips Ormonde Fitzpatrick
    Level 19, 133 Castlereagh Street

    Adelaide office
    Phillips Ormonde Fitzpatrick
    Level 5/75 Hindmarsh Square

A light lunch will be provided. Please advise of any dietary requirements.

If any of your colleagues are interested in attending, please feel free to forward this invitation to them.

Seminar attendees may be eligible to claim points towards their professional development/education. Please refer to your relevant guidelines for more information.